Trial NCT04160195

View at ClinicalTrials.gov 
Org. Study IDs: 200008
Secondary IDs: 20-C-0008

Last trial update was posted on 2022-02-15

MeSH Interventions

Cyclophosphamide Fludarabine

MeSH Conditions

Hodgkin Disease Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma Lymphoma, B-Cell Lymphoma, Non-Hodgkin

Other Conditions

B-Cell Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia Lymphoma, Non-hodgkins

Stopping Reasons

The original principal investigator left the National Institutes of Health (NCI) and the decision was made to close the study to enrollment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID